Literature DB >> 10856164

Unique mechanistic features of allergic rhinitis.

A Togias1.   

Abstract

Symptoms of allergic rhinitis are produced by inflammatory mediators that are released upon activation of mast cells by antigen-IgE interaction. These mediators target the end organs directly or indirectly. Stimulation of sensory nerves by histamine, for example, leads to sneezing, pruritus, rhinorrhea, and nasal congestion. The clinical presentation of allergic rhinitis is also characterized by the phenomenon of hyperresponsiveness to nonallergic stimuli, such as cold air and various irritants. This phenomenon is believed to result from the effect of allergic inflammation on the sensory nerves that supply the upper airway mucosa. Various nonallergic triggers have been shown to act on the nasal mucosa through sensorineural stimulation. In allergic rhinitis, responsiveness to these stimuli is increased compared with the healthy state. A similar phenomenon is observed against such products of the allergic reaction as his-tamine and bradykinin. Also, in allergic rhinitis, stimulation of sensory nerves per se can produce inflammatory changes, a phenomenon known as neurogenic inflammation. The mechanism behind the development of sensorineural hyperresponsiveness and of increased propensity for neurogenic inflammation is unknown. However, evidence exists that the neurotrophin nerve growth factor, which can induce all these changes on sensory nerves, is produced in the human nasal mucosa and found in higher quantities in nasal secretions of patients with perennial allergic rhinitis as compared with healthy control subjects. Also, nerve growth factor is acutely released into nasal fluids after allergen provocation of patients with allergic disease. In patients with asthma of atopic origin, allergic rhinitis is almost ubiquitous. Because the nose is the air conditioner of the respiratory system, its dysfunction may negatively affect the lower airways. In addition to the conditioning of inhaled air, the association between allergic rhinitis and asthma may involve various mechanisms. For example, allergen provocation in the nose of a patient with asthma can lead to reductions in pulmonary function and to increased lower airway responsiveness after several hours. Also, nasal inflammation may propagate through a systemic route to affect the lower airways.

Entities:  

Mesh:

Year:  2000        PMID: 10856164     DOI: 10.1067/mai.2000.106885

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  17 in total

1.  Rhinitis in children and adolescents with asthma: Ubiquitous, difficult to control, and associated with asthma outcomes.

Authors:  Alkis Togias; Peter J Gergen; Jack W Hu; Denise C Babineau; Robert A Wood; Robyn T Cohen; Melanie M Makhija; Gurjit K Khurana Hershey; Carolyn M Kercsmar; Rebecca S Gruchalla; Andrew H Liu; Emily Wang; Haejin Kim; Carin I Lamm; Leonard B Bacharier; Dinesh Pillai; Steve M Sigelman; James E Gern; William W Busse
Journal:  J Allergy Clin Immunol       Date:  2018-09-11       Impact factor: 10.793

2.  International Consensus Statement on Allergy and Rhinology: Allergic Rhinitis.

Authors:  Sarah K Wise; Sandra Y Lin; Elina Toskala; Richard R Orlandi; Cezmi A Akdis; Jeremiah A Alt; Antoine Azar; Fuad M Baroody; Claus Bachert; G Walter Canonica; Thomas Chacko; Cemal Cingi; Giorgio Ciprandi; Jacquelynne Corey; Linda S Cox; Peter Socrates Creticos; Adnan Custovic; Cecelia Damask; Adam DeConde; John M DelGaudio; Charles S Ebert; Jean Anderson Eloy; Carrie E Flanagan; Wytske J Fokkens; Christine Franzese; Jan Gosepath; Ashleigh Halderman; Robert G Hamilton; Hans Jürgen Hoffman; Jens M Hohlfeld; Steven M Houser; Peter H Hwang; Cristoforo Incorvaia; Deborah Jarvis; Ayesha N Khalid; Maritta Kilpeläinen; Todd T Kingdom; Helene Krouse; Desiree Larenas-Linnemann; Adrienne M Laury; Stella E Lee; Joshua M Levy; Amber U Luong; Bradley F Marple; Edward D McCoul; K Christopher McMains; Erik Melén; James W Mims; Gianna Moscato; Joaquim Mullol; Harold S Nelson; Monica Patadia; Ruby Pawankar; Oliver Pfaar; Michael P Platt; William Reisacher; Carmen Rondón; Luke Rudmik; Matthew Ryan; Joaquin Sastre; Rodney J Schlosser; Russell A Settipane; Hemant P Sharma; Aziz Sheikh; Timothy L Smith; Pongsakorn Tantilipikorn; Jody R Tversky; Maria C Veling; De Yun Wang; Marit Westman; Magnus Wickman; Mark Zacharek
Journal:  Int Forum Allergy Rhinol       Date:  2018-02       Impact factor: 3.858

Review 3.  Allergic rhinitis in children.

Authors:  W E Berger
Journal:  Curr Allergy Asthma Rep       Date:  2001-11       Impact factor: 4.806

Review 4.  Allergic rhinitis in children : diagnosis and management strategies.

Authors:  William E Berger
Journal:  Paediatr Drugs       Date:  2004       Impact factor: 3.022

5.  Rhinitis in the geriatric population.

Authors:  Jayant M Pinto; Seema Jeswani
Journal:  Allergy Asthma Clin Immunol       Date:  2010-05-13       Impact factor: 3.406

6.  The pathophysiology, diagnosis and treatment of allergic rhinitis.

Authors:  Yang-Gi Min
Journal:  Allergy Asthma Immunol Res       Date:  2010-03-24       Impact factor: 5.764

7.  Pathophysiology of nasal congestion.

Authors:  Robert M Naclerio; Claus Bachert; James N Baraniuk
Journal:  Int J Gen Med       Date:  2010-04-08

Review 8.  The link between allergic rhinitis and asthma: a role for antileukotrienes?

Authors:  H Kim; J Bouchard; P M Renzi
Journal:  Can Respir J       Date:  2008-03       Impact factor: 2.409

Review 9.  Montelukast in the treatment of allergic rhinitis: an evidence-based review.

Authors:  Anjuli Nayak; Ronald B Langdon
Journal:  Drugs       Date:  2007       Impact factor: 9.546

Review 10.  Is Allergen Immunotherapy in Children Disease Modifying? A Review of the Evidence.

Authors:  Amanda K Rudman Spergel; Michael Minnicozzi; Lisa M Wheatley; Alkis Togias
Journal:  Curr Allergy Asthma Rep       Date:  2018-07-11       Impact factor: 4.806

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.